ATE321024T1 - Verfahren zur herstellung von oxazolidinonverbindungen - Google Patents

Verfahren zur herstellung von oxazolidinonverbindungen

Info

Publication number
ATE321024T1
ATE321024T1 AT01987740T AT01987740T ATE321024T1 AT E321024 T1 ATE321024 T1 AT E321024T1 AT 01987740 T AT01987740 T AT 01987740T AT 01987740 T AT01987740 T AT 01987740T AT E321024 T1 ATE321024 T1 AT E321024T1
Authority
AT
Austria
Prior art keywords
oxazolidinone compounds
butylcarbamoyl
tert
producing
producing oxazolidinone
Prior art date
Application number
AT01987740T
Other languages
English (en)
Inventor
William R Perrault
Robert C Gadwood
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE321024T1 publication Critical patent/ATE321024T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01987740T 2000-10-17 2001-10-17 Verfahren zur herstellung von oxazolidinonverbindungen ATE321024T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24112200P 2000-10-17 2000-10-17

Publications (1)

Publication Number Publication Date
ATE321024T1 true ATE321024T1 (de) 2006-04-15

Family

ID=22909351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987740T ATE321024T1 (de) 2000-10-17 2001-10-17 Verfahren zur herstellung von oxazolidinonverbindungen

Country Status (11)

Country Link
US (2) US6833453B2 (de)
EP (1) EP1328509B1 (de)
JP (1) JP4170753B2 (de)
AT (1) ATE321024T1 (de)
AU (1) AU2002224421A1 (de)
CA (1) CA2423599A1 (de)
DE (1) DE60118241T2 (de)
ES (1) ES2256318T3 (de)
MX (1) MXPA03003473A (de)
NZ (1) NZ525923A (de)
WO (1) WO2002032857A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004002973A1 (ja) * 2002-06-28 2005-10-27 株式会社カネカ 光学活性1−置換アミノ−2,3−エポキシプロパンの製造方法並びにその合成中間体およびそれらの製造方法
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
EP1565186B1 (de) * 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5-carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
JP2006522791A (ja) * 2003-04-09 2006-10-05 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗微生物性[3.1.0]ビシクロヘキシルフェニルオキサゾリジノン誘導体および類似体
WO2006034279A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005329423A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
BRPI0515478A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
CN101083982A (zh) 2004-09-20 2007-12-05 泽农医药公司 用于治疗硬脂酰CoA去饱和酶介导的疾病的杂环衍生物
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
US8431714B2 (en) * 2007-04-16 2013-04-30 University Of Southern California Synthesis of drug conjugates via reaction with epoxide-containing linkers
EP2033960A3 (de) * 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
ITMI20072359A1 (it) * 2007-12-18 2009-06-19 Dipharma Francis Srl Procedimento per la preparazione di derivati ossazolidinonici
EP2163547A1 (de) 2008-09-16 2010-03-17 Unión Químico Farmacéutica, S.A. (UQUIFA) Verfahren für die Herstellung eines antibakteriellen Oxazolidinon-Wirkstoffs und Zwischenprodukte davon
CN103025730A (zh) 2010-04-30 2013-04-03 印第安纳大学研究及科技有限公司 制备利奈唑胺的方法
WO2012153155A1 (en) * 2011-05-06 2012-11-15 Egis Gyógyszergyár Nyilvãnosan Müködö Részvény-Társaság Process for the preparation of a rivaroxaban and intermediates formed in said process
AU2012277738A1 (en) 2011-06-30 2014-01-16 Dsm Ip Assets B.V. Silicone-containing monomer
CN103254148B (zh) * 2012-02-15 2016-04-13 浙江海正药业股份有限公司 利奈唑胺中间体的制备方法
EP2834235A1 (de) 2012-04-06 2015-02-11 Indiana University Research and Technology Corporation Verfahren zur herstellung von rivaroxaban
CN104327007B (zh) * 2014-10-20 2016-07-27 安徽师范大学 3,4,5-三取代噁唑烷酮类化合物及其制备方法
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
US11608320B2 (en) 2020-02-02 2023-03-21 Kuwait University Oxazolidinone hydroxamic acid derivatives
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
WO2024035618A1 (en) * 2022-08-10 2024-02-15 Merck Sharp & Dohme Llc Processes for preparing oxazolidinone compounds

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180089A (en) 1967-10-20 1970-02-04 Delalande Sa Acetylenic Derivatives of 2-Oxazolidinones and processes of preparation
FR2356422A1 (fr) 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
LU80081A1 (fr) 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2500450A1 (fr) 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
ES8506659A1 (es) 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5225565A (en) 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5164510A (en) 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5182403A (en) 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
US5182296A (en) 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
US5231188A (en) 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
WO1993001174A1 (en) 1991-07-08 1993-01-21 Glaxo Group Limited Thiazolidine derivatives and their use as anti-viral compounds
DK0610265T3 (da) 1991-11-01 1997-06-09 Upjohn Co Substituerede aryl- og heteroarylphenyloxazolidioner, som kan anvendes som antibakterielle midler
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
ATE204277T1 (de) 1994-10-26 2001-09-15 Upjohn Co Phenyloxazolidinone mit antimikrobieller wirkung
CN1046520C (zh) 1994-11-15 1999-11-17 法玛西雅厄普约翰美国公司 二环噁嗪及噻嗪噁唑烷酮抗菌剂
US6262278B1 (en) 1995-03-14 2001-07-17 President And Fellows Of Harvard College Stereoselective ring opening reactions
JP3796280B2 (ja) 1995-04-17 2006-07-12 バイエルクロップサイエンス株式会社 1−(2−クロロフエニル)−5(4h)−テトラゾリノンの製造方法
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
ATE257829T1 (de) 1995-09-15 2004-01-15 Upjohn Co Aminoaryl oxazolidinone n-oxide
WO1999003764A1 (en) 1997-07-16 1999-01-28 Systemation Engineered Products, Inc. Tray handling apparatus
DE19730847A1 (de) 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
EP0899353B1 (de) 1997-08-28 2004-05-12 Alps Electric Co., Ltd. Verfahren zum Sintern einer glasartige Eisenlegierungen
NZ504372A (en) * 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
CA2351062A1 (en) 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
US6605732B1 (en) * 1999-05-03 2003-08-12 Aerojet Fine Chemicals Llc Clean, high-yield preparation of S,S and R,S amino acid isosteres
MXPA02000985A (es) 1999-07-28 2002-07-30 Upjohn Co Oxazolidinonas y su uso como antiinfecciosos.
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
PE20010851A1 (es) 1999-12-14 2001-08-17 Upjohn Co Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
NZ520696A (en) * 2000-02-10 2004-03-26 Upjohn Co Piperazine amide substituted oxazolidinone thioamides useful for treating bacteria infections

Also Published As

Publication number Publication date
NZ525923A (en) 2005-11-25
EP1328509B1 (de) 2006-03-22
US20040143131A1 (en) 2004-07-22
US20020086900A1 (en) 2002-07-04
DE60118241D1 (de) 2006-05-11
EP1328509A1 (de) 2003-07-23
US6998420B2 (en) 2006-02-14
DE60118241T2 (de) 2006-12-28
WO2002032857A1 (en) 2002-04-25
ES2256318T3 (es) 2006-07-16
JP2004511539A (ja) 2004-04-15
AU2002224421A1 (en) 2002-04-29
MXPA03003473A (es) 2003-08-19
US6833453B2 (en) 2004-12-21
JP4170753B2 (ja) 2008-10-22
CA2423599A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
ATE321024T1 (de) Verfahren zur herstellung von oxazolidinonverbindungen
ATE374767T1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
DE60127977D1 (de) Verfahren zur herstellung von zähen, wärmehärtenden gegenständen und die wärmehärtenden gegenstände so hergestellt
DE50303413D1 (de) Befestigungsmittel und Verfahren zu seiner Herstellung
ATE450523T1 (de) Verfahren zur herstellung von 3-halogen-4,5- dihydro-1 h-pyrazolen
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
DE60225092D1 (de) Ein Verfahren zur Herstellung von Perindopril, analogen Verbindungen dazu sowie Salzen davon unter Verwendung von 2,5-Dioxooxazolidin-Zwischenprodukten
DE60200038D1 (de) Verpackungsmaterial, Verfahren zu seiner Herstellung, sowie daraus hergestellte Verpackung
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE350372T1 (de) Verfahren und oxazolidin zwischenprodukt zur herstellung von taxanen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
ATE501129T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethyl-1,3-thiazol
DE50103009D1 (de) Verfahren zur herstellung von 2-alkyl-3-chlorphenolen
ATE500247T1 (de) Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor
ATE396166T1 (de) Verfahren zur herstellung von 2,3-cis- substituierten 2-arylpropenalen
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties